<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2 on Name Unknown</title>
    <link>/publication_types/2/</link>
    <description>Recent content in 2 on Name Unknown</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 01 Apr 2018 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="/publication_types/2/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?</title>
      <link>/publication/gbm_meta-analysis1/</link>
      <pubDate>Sun, 01 Apr 2018 00:00:00 +0000</pubDate>
      
      <guid>/publication/gbm_meta-analysis1/</guid>
      <description>We examined the landscape of trials in glioblastoma registered on ClinicalTrials.gov between 2005-2016. Our findings show low patient enrollment, long trial duration, disproportionate allocation of patient to unsuccessful phase III trials, and lack of randomization in phase II.</description>
    </item>
    
    <item>
      <title>Divining responder populations from survival data</title>
      <link>/publication/diving-responder-pops/</link>
      <pubDate>Tue, 01 Sep 2015 00:00:00 +0000</pubDate>
      
      <guid>/publication/diving-responder-pops/</guid>
      <description>We simulated Kaplan-Meier survival curves with varying prognostic and predictive biomarker subgroups to understand whether KM curve shape might be an indicator of underlying patient heterogeneity.</description>
    </item>
    
  </channel>
</rss>